Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs. Stepanov A, Belyy A, Kasheverov I, Rybinets A, Dronina M, Dyachenko I, Murashev A, Knorre V, Sakharov D, Ponomarenko N, et al. Biotechnol Lett. 2016 Apr 21. Epub 2016 Apr 21. PMID: 27099070. Abstract CommentRecommendBookmarkWatch